Tender detail
Abaloparatide medicine rebate agreement
Summary
The tender concerns the supply or procurement of medicines for the active substance abaloparatide and aims to conclude a non-exclusive medicine rebate agreement. The agreement will enter into force on 1 August 2026 and end on 31 July 2028, or earlier if an exclusive agreement enters into force. The bidder must note that the contract requires the medicines to which the rebate will apply to be specified.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.